Driver mutations and cancer
No description yet. This curated deck is ready for daily study.
Card preview (24)
Explain the differences between oncogenes vs tumour suppressor
Oncogenes- genes Is mutated. As result it causes abbarent cell cycle progression, usually genes involved in positive cell cycle progression, cyclin D1, CdKs, if you see gene amplificaiton or mutation that results in cell proliferation Tumor suppressor genes - genes that hit brakes on cell cycle progression, p53, usually you see loss of funct or delection in cancer cells
Driver vs passanger mutations
driver - mutation that provides selective growth advantage (happen in oncogenes and tumor suppressors) Mutations that silence tumor suppressors Stops the cell from pressing on the break. Also if they happen on oncogenes, they would be gain of function mutation Passanger - mutation that does not provide selective growth advantage. Happen due to increase genomic instability, consequence of cancer
What is the normal, unmutated counterpart of an oncogene called?
proto oncogene
What are the hallmarks of cancer
sustaining proliferative signaling evating growth suppressors avoiding immune destruction enablin replicative immortality inducing vasulature genome instability and mutation resisting cell death deregulating cell metabolism
How did they discover oncogenes
RSV - sous sarcoma virus, found in chickens the virus induced tumors Normally cells have Contact inhibition, cells stop dividing if it is surrounded if you infect normal cell with the RSV it will not longer have contact inhibition
How does RSV cause cancer
Rous sarcoma virus Virus hijacks host machinery after its integrated into genome it adds its virus gene into host DNA src gene which helps with proliferation(usually there are only 2 copies in gene but it can add another) src is example of proto oncogene, its a non-receptor tyrosine kinase
Oncogenes vs proto oncogenes
oncogenes - mutated version of genes that make proteins, important to signal transduciton pathway(receptors, kinases, trans factors), leads to cell transformation proto oncogenes - normal, unmutated counterpart of oncogenes, usually gain of funct mutation ex src - When proto oncogene src is integrated into the host DNA then it becomes oncogene
What is the basement membrane
The basement membrane is no longer present in invasive cancers The invasion through memb is what we call matastasis
What are some important oncogenes
Her2 is example of tyrosince kinarse Part of epidermal growht factor family Stimulates growth, prolifereation when it is active Myc stimulates cyclin d1 expression Cyclin d1 is also protooncogene
How were tumor suppressor genes disccovered as they relate to cancer
through inheritance of retinoblastoma- binds to** E2F** and functions as a repressor to repress cyclin E,A is a recessive loss of function scientist found that those with history of retinoblastoma are more likely to get it in both eyes. because they start with mutation in at least 1 copy of gene.
what are the important tumor suppressors
P21 - cyclin dependant kinase inhibitor (CDK), stops cell cycle if DNA is damaged, related to p53 p53 - apoptosis transcription factor retinoblastoma gene -inhibits too much cell growth
What is the primary mechanism of action for p53 mutations in cancer?
Unlike many other tumour suppressors, p53 often involves missense mutations that lead to loss of function.
What are diff mutations required for oncogenes and tumor supressor driver mutations
onco - Are dominant. * gene amplification, in some cases activating GOF missense mutations tumor suppressor - Are recessive. * Arise by focal deletions or nonsense, frameshift, and splice-site mutations. In some cases (e.g., p53) missense mutations.
What does heterogenous mean for cancer and example
the cells within a tumor do not share the same protein receptors, diff parts of tumor will respond to diff treatments ex. estrogen, progesterone and Her2 receptors. in breast cancer. difficult to treat cells that do not have any of their receptors
what is two hit hypothesis
tumour suppressors require both copies of a gene to be inactivated to drive cancer
what are types of sequencing to id DNA problems
targeted panel - only look at genes that are known related to disease whole exome - seq only exonic regions of protein coding genes, only look at coding region, mid speed whole genome - all genome is seq, is expensive
What is the role of Fluorescence in situ hybridization (FISH) in cancer diagnostics?
It is used to detect and locate specific DNA sequences on chromosomes, helping identify genetic aberrations. the genes glow
What is orderof DNA packaging
Nucleosome - single unit of DNA around a core of Histones Cromatin - severale repeating nucleosome units euchromatin - if transcriptionally acive Heterochromatin - silent in transcription
What is epigenetic gene regulation, and types
A change in gene expression that occurs without a change in the underlying DNA sequence. has histone, DNA and chromatin remodelling
How are histones modelled to regulate transcripton (Hdac, HATS)
acetylation - histone acetylases(HATs) adds acetyl group, makes DNA neutral, can be read, activates gene, deacetylation - Histone deacetylases (HDACs) silencces gene, takes away acetyl group, DNA is more tightly wrapped around histone bc hist is pos and DNA is now neg methylation
How is dna modelled to regulate transcritpno (MecP2)
Methylation of cytosine nucl next to guanine nucl (CpG dinucleotide) CpG often found in gene regulatory regions DNA methly transfereases (DMNTs)- add methyl groups methyl group to cytosine nucleotide, inactivates transcriptionjjd then Readers (ex MeCP2) bind to the meCpG to recruit co repressors like HDACs to go to hetochromatin formation
how is chromatin modelled to regulate transcription (3) what is complex called
through multi protein complexes, in ATP activated manner ex SWI/SNF (ARID1A is part of this) complexes, the complexes can have diff parts which dictate function 1. slide nucleosome out of way 2. evict nucleosome 3. excahnge nucleosome
What defines the Triple Negative Breast Cancer (TNBC) subtype?
Do not have expression for receptors of ER, PR or Her2